Meclizine seasickness medication and its effect on central nervous system oxygen toxicity in a murine model
Diving and Hyperbaric Medicine Journal · 2024
DOI: 10.28920/dhm54.4.296-300 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diving and Hyperbaric Medicine Journal, 2024. Verfasst von Guy Wiener und 2 weiteren Autor:innen. Beteiligte Einrichtung: Motion Sickness and Human Performance Laboratory, The Israel Naval Medical Institute, IDF Medical Corps, Haifa, Israel. Hauptthemen laut MEDLINE: Seizures, Oxygen, Meclizine, Hyperbaric Oxygenation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Diving utilising closed circuit pure oxygen rebreather systems has become popular in professional settings. One of the hazards the oxygen diver faces is central nervous system oxygen toxicity (CNS-OT), causing potentially fatal convulsions. At the same time, divers frequently travel by boat, often suffering seasickness. The over-the-counter medication meclizine is an anticholinergic and antihistaminergic agent that has gained popularity in the treatment of seasickness. Reports have shown the inhibitory effect that acetylcholine has on glutamate, a main component in the mechanism leading to CNS-OT seizure. The goal of the present study was to test the effect of meclizine on the latency to CNS-OT seizures under hyperbaric oxygen conditions.
Methods
Twenty male mice were exposed twice to 608 kPa (6 atmospheres) absolute pressure while breathing oxygen after administration of control solution (carboxymethyl cellulose solvent) or drug solution (meclizine) in a randomised crossover design. Latency to tonic-clonic seizures was visually measured.
Results
Mean latency to seizure did not significantly differ between the control group (414 s, standard deviation [SD] 113 s) and meclizine group (434 s, SD 174 s).
Conclusions
Based on results from this animal model, meclizine may be an appropriate option for divers suffering from seasickness, who plan on diving using pure oxygen rebreather systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Motion Sickness and Human Performance Laboratory, The Israel Naval Medical Institute, IDF Medical Corps, Haifa, Israel.
- Corresponding author: Guy Wiener, Motion Sickness and Human Performance Laboratory, The Israel Naval Medical Institute (INMI), Box 22, Rambam Health Care Campus, P.O. Box 9602, 3109601 Haifa, Israel, ORCiD: 0009-0007-87…
Zitieren
APA
Wiener, G., Jamison, A., & Tal, D. (2024). Meclizine seasickness medication and its effect on central nervous system oxygen toxicity in a murine model. Diving and Hyperbaric Medicine Journal. https://doi.org/10.28920/dhm54.4.296-300
Vancouver
Wiener G, Jamison A, Tal D. Meclizine seasickness medication and its effect on central nervous system oxygen toxicity in a murine model. Diving and Hyperbaric Medicine Journal. 2024. doi:10.28920/dhm54.4.296-300
BibTeX
@article{Wiener2024,
author = {Wiener, Guy and Jamison, Anna and Tal, Dror},
title = {Meclizine seasickness medication and its effect on central nervous system oxygen toxicity in a murine model},
journal = {Diving and Hyperbaric Medicine Journal},
year = {2024},
doi = {10.28920/dhm54.4.296-300}
}
EUVIMED